AXIM (AXIM Biotechnologies) Net Income: $0.14 Mil (TTM As of Jun. 2025)

What is AXIM Biotechnologies Net Income?

AXIM Biotechnologies AXIM -6.17% Net Income is $0.14 Mil as of Jun. 2025.

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. AXIM Biotechnologies's Net Income for the three months ended in Jun. 2025 was $0.37 Mil. Its Net Income for the trailing twelve months (TTM) ended in Jun. 2025 was $0.14 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. AXIM Biotechnologies's Earnings per Share (Diluted) for the three months ended in Jun. 2025 was $0.00.

AXIM Biotechnologies (OTCPK:AXIM) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

AXIM Biotechnologies's Earnings per Share (Diluted) (EPS) for the quarter that ended in Jun. 2025 is calculated as

Earnings per Share (Diluted) (Q: Jun. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(0.37	-	0)	/	332.957
	=	0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.

Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.

AXIM Biotechnologies Net Income Related Terms

AXIM Biotechnologies Net Income Historical Data

* Premium members only.

The historical data trend for AXIM Biotechnologies's Net Income can be seen below:

AXIM Biotechnologies Net Income Chart

AXIM Biotechnologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income

Get a 7-Day Free Trial

-6.41

-16.03

-6.24

-8.06

-3.52

AXIM Biotechnologies Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25	Jun25
Net Income	Get a 7-Day Free Trial															-0.29	-2.27	0.00	-0.23	0.37

AXIM Biotechnologies Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

AXIM Biotechnologies's Net Income for the fiscal year that ended in Dec. 2024 is calculated as

	Net Income		(A: Dec. 2024 )
=	Pre-Tax Income	+	Tax Provision	+	Net Income (Discontinued Operations)	+	Others
=	-3.52	+	0	+	0	+	0
=	-3.52

AXIM Biotechnologies's Net Income for the quarter that ended in Jun. 2025 is calculated as

	Net Income		(Q: Jun. 2025 )
=	Pre-Tax Income	+	Tax Provision	+	Net Income (Discontinued Operations)	+	Others
=	0.37	+	0	+	0	+	0
=	0.37

Net Income for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.14 Mil.

Frequently Asked Questions Learn more about Net Income →

What does a Net Income of $0.14 Mil mean?

AXIM Biotechnologies (AXIM) has a Net Income of $0.14 Mil as of Jun. 2025. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on AXIM Biotechnologies and its competitors.

Is AXIM Biotechnologies' Net Income too high?

AXIM Biotechnologies' current Net Income is $0.14 Mil.

How does AXIM Biotechnologies' Net Income compare to ZVSA and HEPA?

AXIM Biotechnologies' Net Income of $0.14 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Net Income for a Biotechnology company?

A good Net Income depends on the Biotechnology industry context. However, Net Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Net Income mean?

A high Net Income can signal that a stock is expensive relative to its fundamentals. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on AXIM Biotechnologies and its competitors. AXIM Biotechnologies's current Net Income is $0.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is AXIM Biotechnologies stock overvalued right now?

AXIM Biotechnologies (AXIM) has a current Net Income of $0.14 Mil. The current Net Income is $0.14 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Net Income calculated?

Net Income is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current Net Income is $0.14 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Industry Healthcare Biotechnology

Comparable Companies ZVSA HEPA ISCO BPTH ABPO SCNI VBIO EVFM LYRA CLSDQ VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121

Website https://www.aximbiotech.com

AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.